ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "A16" (163)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
What is an ATC-Code?ATC-Overview
Levocarnitine (A16AA01) 4 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP  Carnitene 1.0 g/5.0 ml520.0738.2510 %Injection solution: LevocarnitinumAlfasigma Schweiz AGB / SLG
L IPCI Carnitene3093.13117.7010 %Chewing tablets: Levocarnitinum 1 gAlfasigma Schweiz AGB / SLG
L IPCI Carnitene 1 g/10 ml10 x 10 ml19.6937.8510 %Solution (oral): LevocarnitinumAlfasigma Schweiz AGB / SLG
  IPCI Carnitene40 mlk.A.Sirup: LevocarnitinumAlfasigma Schweiz AGBG
Mercaptamine (A16AA04) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IPCI Procysbi 25 mg60329.25374.5010 %gélules gastro-résistantes: Mercaptaminum 25 mgChiesi SAB / SLG
L IPCI Procysbi 75 mg2504115.634492.4010 %gélules gastro-résistantes: Mercaptaminum 75 mgChiesi SAB / SLG
Carglumic Acid (A16AA05) 2 products WHO-DDD 
Page 1 of 2: 12>>
  IPCI Carbaglu 200 mg5k.A.Tabletten zur Herstellung einer Suspension zum Einnehmen: Acidum Carglumicum 200 mgRecordati AGBG
  IPCI Carbaglu 200 mg60k.A.Tabletten zur Herstellung einer Suspension zum Einnehmen: Acidum Carglumicum 200 mgRecordati AGBG
Imiglucerase (A16AB02) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IP  Cerezyme 400 UDurchstechflasche(n)1511.851660.6510 %poudre pour solution à diluer pour perfusion: Imiglucerasum 400 USanofi-Aventis
(Suisse) SA		B / SLG
Agalsidase Alfa (A16AB03) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IPCI ReplagalDurchstechflasche(n)1787.891960.8510 %Concentrate for infusion: Agalsidasum Alfa 1 mgTakeda Pharma AGA / SLG
Agalsidase Beta (A16AB04) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
 SIPIP  Fabrazyme 5 mg 478.32536.6010 %poudre pour solution à diluer pour perfusion: Agalsidasum Beta 5 mgSanofi-Aventis
(Suisse) SA		A / SLG
 SIPIPCI Fabrazyme 35 mgDurchstechflasche(n)3348.273657.8510 %poudre pour solution à diluer pour perfusion: Agalsidasum Beta 35 mgSanofi-Aventis
(Suisse) SA		A / SLG
Alglucosidase Alfa (A16AB07) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
LSIPIP  MyozymeDurchstechflasche(n)484.34514.3510 %Poudre pour solution à diluer pour perfusion: Alglucosidasum Alfa 50 mgSanofi-Aventis
(Suisse) SA		A / SLG
 SIPIP  Myozyme25 Durchstechflasche(n)k.A.Poudre pour solution à diluer pour perfusion: Alglucosidasum Alfa 50 mgSanofi-Aventis
(Suisse) SA		AG
Galsulfase (A16AB08) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
LSIPIP  NaglazymeDurchstechflasche(n) à 5 ml1329.671462.5010 %Concentrate for infusion: Galsulfasum 5 mgDRAC AGB / SLG
Idursulfase (A16AB09) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
LSIPIPCI ElapraseDurchstechflasche(n)2580.222822.5510 %Concentrate for infusion: Idursulfasum 2 mg/mlTakeda Pharma AGA / SLG
Elosulfase Alfa (A16AB12) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IP  Vimizim 5mg/5mlDurchstechflasche(n)k.A.Concentrate for infusion: Elosulfasum Alfa 5mg / 5mlDRAC AGBG
Asfotase Alfa (A16AB13) 20 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IPCIPPStrensiq 40 mg/ml12k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 40 mg/ml12k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 40 mg/ml12k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 100 mg/ml12k.A.Injection solution: Asfotasum Alfa 100 mg/mlAlexion Pharma GmbHAG
L IPCIPPStrensiq 40 mg/ml1210677.3711262.8010 %Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHA / SLG
L IPCIPPStrensiq 40 mg/ml1216609.2417348.9010 %Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHA / SLG
L IPCIPPStrensiq 40 mg/ml1223727.4924652.2010 %Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHA / SLG
L IPCIPPStrensiq 100 mg/ml1247454.9748996.6010 %Injection solution: Asfotasum Alfa 100 mg/mlAlexion Pharma GmbHA / SLG
  IPCIPPStrensiq 40 mg/ml k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 40 mg/ml k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 40 mg/ml k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 40 mg/ml k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 40 mg/ml k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 40 mg/ml k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 40 mg/ml k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 40 mg/ml k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 40 mg/ml12k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 40 mg/ml12k.A.Injection solution: Asfotasum Alfa 40 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 100 mg/ml k.A.Injection solution: Asfotasum Alfa 100 mg/mlAlexion Pharma GmbHAG
  IPCIPPStrensiq 100 mg/ml k.A.Injection solution: Asfotasum Alfa 100 mg/mlAlexion Pharma GmbHAG
Pegunigalsidase Alfa (A16AB20) 3 products WHO-DDD 
Page 1 of 2: 12>>
  IP  Elfabrio 20 mg/10 ml 1864.182043.8010 %Concentrate for infusion: Pegunigalsidasum Alfa 20mg / 10mlChiesi SAA / SLG
  IP  Elfabrio 20 mg/10 ml5k.A.Concentrate for infusion: Pegunigalsidasum Alfa 20mg / 10mlChiesi SAAG
  IP  Elfabrio 20 mg/10 ml10k.A.Concentrate for infusion: Pegunigalsidasum Alfa 20mg / 10mlChiesi SAAG
Avalglucosidase Alfa (A16AB22) 3 products WHO-DDD 
Page 1 of 2: 12>>
L IP  Nexviadyme 100 mg 988.961049.5510 %poudre pour solution à diluer pour perfusion: Avalglucosidasum Alfa 100 mgSanofi-Aventis
(Suisse) SA		A / SLG
  IP  Nexviadyme 100 mg5k.A.poudre pour solution à diluer pour perfusion: Avalglucosidasum Alfa 100 mgSanofi-Aventis
(Suisse) SA		AG
  IP  Nexviadyme 100 mg10k.A.poudre pour solution à diluer pour perfusion: Avalglucosidasum Alfa 100 mgSanofi-Aventis
(Suisse) SA		AG
Anethole Trithione (A16AX02) 1 products WHO-DDD 
Page 1 of 2: 12>>
  IPCI Sulfarlem S 2560 Dragée(s)k.A.Dragées: Anetholtrithionum 25 mgRecordati AGDG
Sodium Phenylbutyrate (A16AX03) 1 products WHO-DDD 
Page 1 of 2: 12>>
L IPCI Pheburane 483 mg/g 430.03484.1010 %Granulat zur Herstellung einer Lösung zum Einnehmen: Natrii Phenylbutyras 483 mgMedius AGB / SLG
Nitisinone (A16AX04) 4 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IPCI Nitisinon NOBEL 5 mg60k.A.Capsules: Nitisinonum 5 mgNOBEL Pharma Schweiz AGBG
  IPCI Nitisinon NOBEL 10 mg60k.A.Capsules: Nitisinonum 10 mgNOBEL Pharma Schweiz AGBG
  IPCI Nitisinon NOBEL 20 mg60k.A.Capsules: Nitisinonum 20 mgNOBEL Pharma Schweiz AGBG
  IPCI Nitisinon NOBEL 4 mg/ml100 mlk.A.Suspension: Nitisinonum 4 mg/mlNOBEL Pharma Schweiz AGBG
Miglustat (A16AX06) 4 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IPCI Zavesca84 Capsule(s)4501.014883.8510 %Capsules: Miglustatum 100 mgJanssen-Cilag AGB / SL / SOG
L IPCI Miglustat Dipharma 100 mg844050.914422.0010 %Capsules: Miglustatum 100 mgDipharma SAB / SL / SGG
L IPCI Opfolda 65 mg4167.63198.7010 %Capsules: Miglustatum 65 mgAmicus Therapeutics
Switzerland GmbH		B / SLG
L IPCI Opfolda 65 mg241005.781110.2510 %Capsules: Miglustatum 65 mgAmicus Therapeutics
Switzerland GmbH		B / SLG
Sapropterin (A16AX07) 11 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IPCI Kuvan30 Tablet(s)608.90692.2510 %Tablets: Sapropterini Dihydrochloridum 100 mgDRAC AGB / SL / SOG
L IPCI Kuvan120 Tablet(s)2435.632665.3010 %Tablets: Sapropterini Dihydrochloridum 100 mgDRAC AGB / SL / SOG
L IPCI Sapropterin Spirig HC 100 mg30487.12567.3010 %Tabletten zur Herstellung einer Lösung zum Einnehmen: Sapropterini Dihydrochloridum 100 mgSpirig HealthCare AGB / SL / SGG
L IPCI Sapropterin Spirig HC 100 mg1201948.502135.5510 %Tabletten zur Herstellung einer Lösung zum Einnehmen: Sapropterini Dihydrochloridum 100 mgSpirig HealthCare AGB / SL / SGG
L IPCI Sapropterin Dipharma 100 mg30487.12567.3010 %compressa dispersibile: Sapropterini Dihydrochloridum 100 mgDipharma SAB / SL / SGG
L IPCI Sapropterin Dipharma 100 mg1201948.502135.5510 %compressa dispersibile: Sapropterini Dihydrochloridum 100 mgDipharma SAB / SL / SGG
L IPCI Sapropterin Dipharma 100 mg30487.12567.3010 %polvere per soluzione orale: Sapropterini Dihydrochloridum 100 mgDipharma SAB / SL / SGG
L IPCI Sapropterin Dipharma 500 mg301704.921870.6010 %polvere per soluzione orale: Sapropterini Dihydrochloridum 500 mgDipharma SAB / SL / SGG
     Sapropterin NOBEL 100 mg30k.A.Tabletten zur Herstellung einer Lösung zum Einnehmen: Sapropterini Dihydrochloridum 100 mgNOBEL Pharma Schweiz AGBG
  IPCI Sapropterin Spirig HC 100 mg30k.A.Tabletten zur Herstellung einer Lösung zum Einnehmen: Sapropterini Dihydrochloridum 100 mgSpirig HealthCare AGBG
  IPCI Sapropterin Spirig HC 100 mg120k.A.Tabletten zur Herstellung einer Lösung zum Einnehmen: Sapropterini Dihydrochloridum 100 mgSpirig HealthCare AGBG
Eliglustat (A16AX10) 3 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IPCI Cerdelga 84 mg5625084.7126044.7010 %Capsules: Eliglustatum 84.4 mgSanofi-Aventis
(Suisse) SA		B / SLG
  IPCI Cerdelga 84 mg14k.A.Capsules: Eliglustatum 84.4 mgSanofi-Aventis
(Suisse) SA		BG
  IPCI Cerdelga 84 mg196k.A.Capsules: Eliglustatum 84.4 mgSanofi-Aventis
(Suisse) SA		BG
Migalastat (A16AX14) 1 products WHO-DDD 
Page 1 of 2: 12>>
L IPCIPPGalafold 123 mg1417664.5918431.6510 %Capsules: Migalastatum 123 mgAmicus Therapeutics
Switzerland GmbH		B / SLG
Lumasiran (A16AX18) 1 products WHO-DDD 
Page 1 of 2: 12>>
  IPCI Oxlumo 94.5 mg / 0.5 ml k.A.Alnylam Switzerland
GmbH		BG
Homöopathika für Verdauungstrakt und Metabolismus (A16AZ) 40 products WHO-DDD 
Page 1 of 2: 12>>
   CIHCuprukehl D410 1 ampoule(s) à 2 ml17.50k.A.Injection solution: Cuprum Gluconicum D4 Aquos (Hab 5A, 5B) 2 mlebi-pharm agBG
   CIHCuprukehl D450 1 ampoule(s) à 2 ml71.00k.A.Injection solution: Cuprum Gluconicum D4 Aquos (Hab 5A, 5B) 2 mlebi-pharm agBG
   CIHFortakehl D5ampoule(s) à 1 ml9.20k.A.Injection solution: Penicillium Roqueforti Aquos D5 Dilutioebi-pharm agBG
   CIHFortakehl D510 1 ampoule(s) à 1 ml63.00k.A.Injection solution: Penicillium Roqueforti Aquos D5 Dilutioebi-pharm agBG
   CIHFortakehl D550 1 ampoule(s) à 1 ml251.00k.A.Injection solution: Penicillium Roqueforti Aquos D5 Dilutioebi-pharm agBG
   CIHSanukehl Cand D5ampoule(s) à 1 mlk.A.Injection solution: Candida Albicans Aquos D5 Dilutioebi-pharm agBG
   CIHSanukehl Cand D510 1 ampoule(s) à 1 mlk.A.Injection solution: Candida Albicans Aquos D5 Dilutioebi-pharm agBG
   CIHSanukehl Cand D550 1 ampoule(s) à 1 mlk.A.Injection solution: Candida Albicans Aquos D5 Dilutioebi-pharm agBG
   CIHSanukehl Salm D610 1 ampoule(s) à 1 mlk.A.ebi-pharm agBG
   CIHSanukehl Salm D650 1 ampoule(s) à 1 mlk.A.ebi-pharm agBG
   CIHFortakehl D310 suppositories21.30k.A.Suppositories: Penicillium Roqueforti D3 Trituratio 200 mgebi-pharm agDG
   CIHSimilasan Magen-Darm-
Beschwerden		15 gk.A.Globules: 4 Active AgentsSimilasan AGDG
   CIHSimilasan Magenbrennen15 gk.A.Globules: 3 Active AgentsSimilasan AGDG
   CIHToxex10 gk.A.Globules: 5 Active Agentsebi-pharm agDG
   CIHFortakehl D420 Capsule(s)43.50k.A.Capsules: Penicillium Roqueforti D4 Trituratio 330 mgebi-pharm agDG
   CIHFortakehl D520 Tablet(s)16.00k.A.Tablets: Penicillium Roqueforti D5 Trituratio 250 mgebi-pharm agDG
   CIHGastricumeel50 Tablet(s)8.90k.A.Tablets: 6 Active Agentsebi-pharm agDG
   CIHSimilasan Magenbrennen60 Tablet(s)k.A.Tablets: 3 Active AgentsSimilasan AGDG
   CIHCuprukehl D330 ml10.80k.A.Drops: Cuprum Gluconicum D3 80 µl/mlebi-pharm agBG
   CIHCuprukehl D3100 ml21.20k.A.Drops: Cuprum Gluconicum D3 80 µl/mlebi-pharm agBG
   CIHFortakehl D510 ml15.50k.A.Drops: Penicillium Roqueforti Aquos D5 Dilutioebi-pharm agDG
   CIHOkoubasan30 mlk.A.ebi-pharm agDG
   CIHToxex50 mlk.A.Drops: 7 Active Agentsebi-pharm agDG
   CIHToxex100 mlk.A.Drops: 7 Active Agentsebi-pharm agDG
   CI Selomida Verdauung30 x 7.5 gk.A.Pulver zur Herstellung einer Lösung zum Einnehmen: 5 Active AgentsSchwabe Pharma AGDG
   CI Gemmo Magenbeschwerden30 mlk.A.Spray zur Anwendung in der Mundhöhle: Ficus Carica e Gemma Recenti D1 (Ph.Eur.Hom. 2.1.3) 1 mlSpagyros AGDG
   CIHDefaeton50 ml15.70k.A.Tropfen zum Einnehmen: 5 Active Agentsebi-pharm agDG
   CIHMucan50 mlk.A.Tropfen zum Einnehmen: 7 Active Agentsebi-pharm agDG
   CIHMucan100 mlk.A.Tropfen zum Einnehmen: 7 Active Agentsebi-pharm agDG
   CIHSanukehl Cand D610 mlk.A.Tropfen zum Einnehmen und Einreiben: Candida Albicans Extractum Cellulae (Lyophil., Steril.) D6 (Hab 5A) 1 mlebi-pharm agBG
   CIHSanukehl Salm D610 mlk.A.Tropfen zum Einnehmen und Einreiben: Salmonella Enteritidis Extractum Cellulae (Lyophil., Steril) D6 (Hab 5A) 1 mlebi-pharm agBG
   CIHDr. Reckeweg R 5 Gastreu50 mlk.A.gouttes buvables: 10 Active AgentsLaboratoire Jacques
Reboh et fils SA		DG
   CIHDr. Reckeweg R 32
Antihidrosin		50 mlk.A.gouttes buvables: 8 Active AgentsLaboratoire Jacques
Reboh et fils SA		DG
   CIHSimilasan Magen-Darm-
Beschwerden		4.5 gk.A.Globules: 4 Active AgentsSimilasan AGDG
   CIHSimilasan Magenbrennen4.5 gk.A.Globules: 3 Active AgentsSimilasan AGDG
   CIHApo-Stom50 ml15.70k.A.Tropfen zum Einnehmen: 6 Active Agentsebi-pharm agDG
     Gasterophyl15 ml6.20k.A.Drops: 9 Active AgentsLaboratoire Dr. E.
Homberger SA		CG
     Gasterophyl30 ml10.30k.A.Drops: 9 Active AgentsLaboratoire Dr. E.
Homberger SA		CG
     Gasterophyl60 ml18.60k.A.Drops: 9 Active AgentsLaboratoire Dr. E.
Homberger SA		CG
     Phytopharma100 mlk.A.Drops: Cynara Scolymus TmPhytopharma SADG
 
ATC-Browser | Drugs A-Z | Recent Registrations
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home